Physician profile
Ivan Dominguez
NPI 1104070705
$36,803.78
in general payments reported to CMS, 2019-2025
23 companies · $6,344 in 2025
The $6,344 reported for 2025 was more than what 87% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $543 · 2021: $313 · 2022: $282 · 2023: $362 · 2024: $3,053 · 2025: $6,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,200 · Food and Beverage: $1,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,200.00 |
| Food and Beverage | $1,559.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $19,536.38 | 2019-2020 | |
| Boston Scientific Corporation | $9,446.70 | 2019-2025 | Eluvia, Angiojet Ultra 5000a, Jetstream Sc |
| Ekos Corporation | $4,642.89 | 2019 | |
| W. L. Gore & Associates, INC. | $1,318.84 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic, INC. | $430.61 | 2024-2025 | Endurant Iis, Symplicity G3, Na |
| Janssen Pharmaceuticals, INC | $387.37 | 2019-2021 | |
| Shape Memory Medical INC. | $332.62 | 2025 | Impede Embolization Plug |
| Inari Medical, INC. | $131.15 | 2019-2020 | |
| Lemaitre Vascular, INC. | $117.65 | 2023 | Artegraft Vascular Graft |
| E.R. Squibb & Sons, L.L.C. | $78.76 | 2019 | |
| Hologic Sales and Service, LLC | $75.00 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Abbott Laboratories | $56.19 | 2022-2024 | Xience Skypoint |
| Bard Peripheral Vascular, INC. | $49.70 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.00 | 2021 | |
| Edwards Lifesciences Corporation | $24.13 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pbg Puerto Rico LLC | $22.28 | 2021 | |
| Silk Road Medical, INC. | $20.85 | 2019 | |
| Philips North America LLC | $18.91 | 2019 | |
| Chiesi USA, INC. | $17.22 | 2022 | |
| Convatec INC. | $16.63 | 2019 | |
| Pfizer INC. | $15.09 | 2019 | |
| Cardinal Health P.R. 120 INC | $11.64 | 2020 | |
| Polarityte, INC. | $8.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Dominguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.